SCHEMBL7209345

SCHEMBL7209345

O=C(Nc1ccc(Br)cc1)c1cc(Br)ccc1NS(=O)(=O)c1cccc2ccncc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC10A2 Q12908 1/20 0.52
SLC10A1 Q14973 1/20 0.52
SLC10A6 Q3KNW5 1/20 0.52
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
KMT2A Q03164 7/20 0.43
MEN1 O00255 6/20 0.43
METAP2 P50579 1/20 0.43
SORT1 Q99523 1/20 0.42
KCNA5 P22460 1/20 0.42
MAPT P10636 3/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ADORA3 P0DMS8 1/20 0.40
SLC6A3 Q01959 1/20 0.40
CCR9 P51686 1/20 0.40
AVPR2 P30518 1/20 0.40
GPR27 Q9NS67 1/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7209360 0.77 EDNRA (0.65) SLC10A2SLC10A1SLC10A6
SCHEMBL7117455 0.77 SLC10A2 (0.60) SLC10A2SLC10A1SLC10A6ALDH1A1LMNA
SCHEMBL7128469 0.77 SLC10A2 (0.60) SLC10A2SLC10A1SLC10A6ALDH1A1LMNA
SCHEMBL7128140 0.76 SLC10A6 (0.61) SLC10A2SLC10A1SLC10A6ALDH1A1LMNA
SCHEMBL7213174 0.76 SLC10A6 (0.61) SLC10A2SLC10A1SLC10A6KMT2AMEN1
SCHEMBL7213043 0.75 MEN1 (0.76) SLC10A2SLC10A1SLC10A6ALDH1A1KMT2A
SCHEMBL7116008 0.75 SLC10A6 (0.85) SLC10A2SLC10A1SLC10A6ALDH1A1LMNA
SCHEMBL27575113 0.74 SLC10A6 (0.56) SLC10A2SLC10A1SLC10A6ALDH1A1LMNA
SCHEMBL7120319 0.74 SLC10A6 (0.76) SLC10A2SLC10A1SLC10A6ALDH1A1LMNA
SCHEMBL7626967 0.74 SLC10A6 (0.68) SLC10A2SLC10A1SLC10A6ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO claimed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed